Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Allergan acquires NASH player Tobira for $1.695bn

Executive Summary

In the first of two acquisitions announced on the same day, both focused on the emerging nonalcoholic steatohepatitis (NASH) market, Allergan PLC bought publicly traded Tobira Therapeutics Inc. for $1.695bn, including approximately $534mm up front plus up to $1.2bn in earn-outs.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Payment Includes Cash
    • Full Acquisition
    • Includes Contract

Related Companies

Advertisement
UsernamePublicRestriction

Register